09/23/2020 12:00 AM EDT
Source: U.S. Senate, Committee on Health, Education, Labor, and Pensions. Published: 9/23/2020. Witnesses in this three-hour, 18-minute Congressional hearing discuss the Department of Health and Human Services’ ongoing response to the COVID-19 pandemic, and how each of their agencies and offices are working to prevent, diagnose, and treat the novel coronavirus SARS-CoV-2. (Video or Multimedia)
09/23/2020 12:00 AM EDT
Source: U.S. House of Representatives, Committee on Energy and Commerce. Published: 9/23/2020. Witnesses in this four-hour, eight-minute Congressional hearing discuss the Affordable Care Act (ACA)’s impact on the status of health coverage amidst COVID-19, and what needs to be done to expand and improve access to quality, affordable health care. (Video or Multimedia)
09/23/2020 12:00 AM EDT
Source: U.S. House of Representatives, Committee on Science, Space, and Technology. Published: 9/23/2020. This one-hour, 17-minute Congressional hearing focuses on how data drives the decision-making at every level of the response to COVID-19, and how ensuring the integrity, transparency, and accuracy of this data is crucial to keeping everyone safe and prepared. (Video or Multimedia)
09/22/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 9/22/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the Clarifi COVID-19 Test Kit. The Clarifi COVID-19 Test Kit is authorized for use with saliva swab specimens collected from individuals suspected of COVID-19 by their healthcare provider. (PDF)
09/22/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 9/22/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the ViroKey SARS-CoV-2 RT-PCR Test v2.0. The ViroKey SARS-CoV-2 RT-PCR Test v2.0 is authorized for use with respiratory specimens collected from individuals suspected of COVID-19 by their healthcare provider. (PDF)
09/21/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 9/21/2020. The Food and Drug Administration (FDA) has issued this 35-page guidance, updated on September 21, 2020, to provide general considerations to assist sponsors in assuring the safety of trial participants in the conduct of clinical trials of medical products, maintaining compliance with good clinical practice (GCP), and minimizing risks to trial integrity during the COVID-19 (coronavirus) pandemic. (PDF)
09/21/2020 12:00 AM EDT
Source: World Health Organization (WHO). Published: 9/21/2020. This four-page document provides interim recommendations from the WHO Strategic Advisory Group of Experts (SAGE) on Immunization for influenza vaccination during the COVID-19 pandemic. It also provides programmatic considerations for national authorities planning and conducting their influenza vaccination programs, as well as research considerations to address current knowledge gaps. (PDF)
09/21/2020 12:00 AM EDT
Source: Center for Health Security [Johns Hopkins University, Bloomberg School of Public Health]. Published: 9/21/2020. This 13-page document undertakes a scientific review of a recent report, released as a preprint put forward by the Rule of Law Society, which presents a theory about the origin of SARS-CoV-2 but offers contradictory and inaccurate information that does not support their argument. (PDF)
09/15/2020 12:00 AM EDT
Source: National Institutes of Health (NIH). Published: 9/15/2020. This five-hour, 47-minute workshop brings together experts in the field to discuss the progress and challenges in obstetric therapeutic research and patient care, share experiences in clinical management of pregnant women and newborns with COVID-19, and explore effective approaches to obstetric therapeutics during the COVID-19 pandemic. (Video or Multimedia)
09/01/2020 12:00 AM EDT
Source: World Health Organization (WHO). Published: 9/2020. Countries can use this 28-page technical guidance to establish or improve national reference laboratory capacity within the national antimicrobial resistance (AMR) surveillance system. Increased laboratory capacity in countries and rapid, accurate diagnostic testing will significantly strengthen global AMR surveillance and diagnostic stewardship. (PDF)
08/08/2020 12:00 AM EDT
Source: Centers for Disease Control and Prevention (CDC). Published: 8/8/2020. Health departments often collaborate with other organizations to improve the health and well-being of their community. This three-page document provides a list of tips for health departments when they are working with community organizations on contact tracing. (PDF)
08/01/2020 12:00 AM EDT
Source: Centers for Disease Control and Prevention (CDC). Published: 8/2020. Case investigation, a core activity in COVID-19 control, is crucial to an effective COVID-19 public health control program. As a management tool for quality assurance for case investigation, this 24-page document will help supervisors and training leads to effectively develop and assess Case Investigators’ interviewing skills. (PDF)
08/01/2020 12:00 AM EDT
Source: National Center for Disaster Medicine and Public Health [Uniformed Services University of the Health Sciences] (NCDMPH). Published: 8/2020. In partnership with the American Red Cross, the National Center for Disaster Medicine and Public Health is creating a curriculum geared toward high school students focusing on applying pressure to stop bleeding, communication in emergencies, situational awareness, and body positioning. This 31-minute video discusses the program. (Video or Multimedia)
08/01/2020 12:00 AM EDT
Source: Robert Wood Johnson Foundation (RWJF). Published: 8/2020. The Sentinel Communities project described on this web page follows the experiences of nine diverse communities to understand how they are responding to and recovering from the COVID-19 crisis. (Text)
05/11/2020 12:00 AM EDT
Source: Office of the Assistant Secretary for Preparedness and Response [U.S. Department of Health and Human Services] (HHS ASPR). Published: 5/11/2020. This two-page document from TRACIE (Technical Resources, Assistance Center, and Information Exchange) responds to a request for guidance resources related to COVID-19 and visitation recommendations for a local retirement condominium community. (PDF)
.png)
No hay comentarios:
Publicar un comentario